Magenta Therapeutics, Inc. vs Aardvark Therapeutics, Inc., risk disclosures compared

3topics both disclose

7only Magenta Therapeutics, Inc.

3only Aardvark Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Magenta Therapeutics, Inc.	Aardvark Therapeutics, Inc.
Business Continuity	1	7
Ransomware	4	4
Cross Border Data Transfer	1	3

Only Magenta Therapeutics, Inc.

Topic	Filings
Internal Control	9
Material Weakness	4
Restatement	3
Consent Order	2
Enforcement Action	2
Regulatory Investigation	2
Data Breach	1

Only Aardvark Therapeutics, Inc.

Topic	Filings
Data Residency	3
Audit Committee Oversight	2
ESG Reporting	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Magenta Therapeutics, Inc. · Aardvark Therapeutics, Inc. · All companies